These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39298113)

  • 1. Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma.
    Verrienti A; Pecce V; Grani G; Del Gatto V; Barp S; Maranghi M; Giacomelli L; Di Gioia C; Biffoni M; Filetti S; Durante C; Sponziello M
    J Endocrinol Invest; 2024 Sep; ():. PubMed ID: 39298113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up.
    Rosignolo F; Sponziello M; Giacomelli L; Russo D; Pecce V; Biffoni M; Bellantone R; Lombardi CP; Lamartina L; Grani G; Durante C; Filetti S; Verrienti A
    J Endocr Soc; 2017 Jan; 1(1):3-13. PubMed ID: 29264441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
    Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
    Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
    Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
    Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X
    Front Genet; 2020; 11():449. PubMed ID: 32508877
    [No Abstract]   [Full Text] [Related]  

  • 8. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
    Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
    J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miR-146a-5p and miR-132-3p as potential diagnostic biomarkers in epilepsy.
    Nomair AM; Mekky JF; El-Hamshary SA; Nomeir HM
    Epilepsy Res; 2023 Mar; 191():107089. PubMed ID: 36801489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-146a-5p is upregulated in serum and cartilage samples of patients with osteoarthritis.
    Skrzypa M; Szala D; Gablo N; Czech J; Pajak J; Kopanska M; Trzeciak M; Gargasz K; Snela S; Zawlik I
    Pol Przegl Chir; 2019 Feb; 91(3):1-5. PubMed ID: 31243168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer.
    Rogucki M; Sidorkiewicz I; Niemira M; Dzięcioł JB; Buczyńska A; Adamska A; Siewko K; Kościuszko M; Maliszewska K; Wójcicka A; Supronik J; Szelachowska M; Reszeć J; Krętowski AJ; Popławska-Kita A
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing.
    Dai D; Tan Y; Guo L; Tang A; Zhao Y
    Eur J Endocrinol; 2020 Jan; 182(1):111-121. PubMed ID: 31721725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA-125a-5p as Potential Diagnostic Biomarkers for Rheumatoid Arthris.
    Safari F; Damavandi E; Rostamian AR; Movassaghi S; Imani-Saber Z; Saffari M; Kabuli M; Ghadami M
    Iran J Allergy Asthma Immunol; 2021 Jun; 20(3):326-337. PubMed ID: 34134454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
    Li M; Song Q; Li H; Lou Y; Wang L
    PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
    Rezaei M; Khamaneh AM; Zarghami N; Vosoughi A; Hashemzadeh S
    BMC Cancer; 2019 Jul; 19(1):690. PubMed ID: 31307429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.
    Graham ME; Hart RD; Douglas S; Makki FM; Pinto D; Butler AL; Bullock M; Rigby MH; Trites JR; Taylor SM; Singh R
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):33. PubMed ID: 26341226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
    Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
    Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
    Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA Expression Profiling-Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes.
    Silaghi H; Pop LA; Georgescu CE; Muntean D; Crișan D; Silaghi P; Lungu I; Nasui BA; Dulf EH; Braicu C; Berindan-Neagoe I; Silaghi CA
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis.
    Zou X; Gao F; Wang ZY; Zhang H; Liu QX; Jiang L; Zhou X; Zhu W
    Chin Med J (Engl); 2020 Nov; 133(21):2543-2551. PubMed ID: 33009019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.